292 related articles for article (PubMed ID: 12775731)
1. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center.
Gill S; Shah A; Le N; Cook EF; Yoshida EM
J Clin Oncol; 2003 Jun; 21(11):2070-6. PubMed ID: 12775731
[TBL] [Abstract][Full Text] [Related]
2. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base.
Al-Refaie WB; Tseng JF; Gay G; Patel-Parekh L; Mansfield PF; Pisters PW; Yao JC; Feig BW
Cancer; 2008 Aug; 113(3):461-9. PubMed ID: 18553367
[TBL] [Abstract][Full Text] [Related]
3. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
[TBL] [Abstract][Full Text] [Related]
4. Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival.
Theuer CP; Nastanski F; Brewster WR; Butler JA; Anton-Culver H
Am Surg; 1999 Oct; 65(10):915-21. PubMed ID: 10515534
[TBL] [Abstract][Full Text] [Related]
5. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics of signet ring cell carcinoma of the stomach.
Kim DY; Park YK; Joo JK; Ryu SY; Kim YJ; Kim SK; Lee JH
ANZ J Surg; 2004 Dec; 74(12):1060-4. PubMed ID: 15574148
[TBL] [Abstract][Full Text] [Related]
7. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
Le A; Berger D; Lau M; El-Serag HB
Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
[TBL] [Abstract][Full Text] [Related]
8. Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors.
Pacelli F; Papa V; Caprino P; Sgadari A; Bossola M; Doglietto GB
Am Surg; 2001 Jul; 67(7):697-703. PubMed ID: 11450793
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients.
Wang JY; Hsieh JS; Huang CJ; Huang YS; Huang TJ
J Surg Oncol; 1996 Sep; 63(1):36-40. PubMed ID: 8841464
[TBL] [Abstract][Full Text] [Related]
11. Poorer prognosis in young patients with gastric cancer?
Lo SS; Kuo HS; Wu CW; Hsieh MC; Shyr YM; Wang HC; Lui WY
Hepatogastroenterology; 1999; 46(28):2690-3. PubMed ID: 10522066
[TBL] [Abstract][Full Text] [Related]
12. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection.
Bentrem D; Wilton A; Mazumdar M; Brennan M; Coit D
Ann Surg Oncol; 2005 May; 12(5):347-53. PubMed ID: 15915368
[TBL] [Abstract][Full Text] [Related]
13. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
[TBL] [Abstract][Full Text] [Related]
14. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
15. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
[TBL] [Abstract][Full Text] [Related]
16. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.
Kim JG; Ryoo BY; Park YH; Kim BS; Kim TY; Im YH; Kang YK
Cancer Chemother Pharmacol; 2008 Feb; 61(2):301-7. PubMed ID: 17429626
[TBL] [Abstract][Full Text] [Related]
18. The prognostic determinants of gastric cancer treatment outcome in Omani Arab patients.
Al-Moundhri MS; Al-Bahrani B; Burney IA; Nirmala V; Al-Madhani A; Al-Mawaly K; Al-Nabhani M; Thomas V; Ganguly SS; Grant CS
Oncology; 2006; 70(2):90-6. PubMed ID: 16601367
[TBL] [Abstract][Full Text] [Related]
19. Management of gastric cancer in Ontario.
Coburn NG; Lourenco LG; Rossi SE; Gunraj N; Mahar AL; Helyer LK; Law C; Rabeneck L; Paszat L
J Surg Oncol; 2010 Jul; 102(1):54-63. PubMed ID: 20578079
[TBL] [Abstract][Full Text] [Related]
20. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival?
Badgwell B; Cormier JN; Krishnan S; Yao J; Staerkel GA; Lupo PJ; Pisters PW; Feig B; Mansfield P
Ann Surg Oncol; 2008 Oct; 15(10):2684-91. PubMed ID: 18649106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
